Alpha-2-Macroglobulin in Saliva as a Noninvasive Glycemic Control Marker in Type 2 Diabetes Mellitus Patient
• 2022
Publication Information
Authors
Amira K. El-Alfy, Medhat A. Khalil
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
ne-modulating capabilities have been discovered for the
multifunctional steroid hormone known as vitamin D. Vitamin D deficiency was found to be linked with advancement
of Chronic liver disease (CLD) as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), as well
as the hepatitis C virus (HCV). Objective: The aim of the current work was to investigate the association between
vitamin D deficiency and HCC in patients with liver cirrhosis. Patients and Methods: Ninety individuals with liver
cirrhosis (LC) participated in this trial. The included subjects were divided into two groups; Group A consisted of 45
cirrhotic patients without HCC, and Group B consisted of 45 cirrhotic patients with HCC. Results: Liver function
tests: INR, ALT, AST, total bilirubin were all statistically substantially higher in group B than in group A (P=0.001,
0.001, 0.001, and 0.011, respectively). However, group B's serum albumin and platelet count were considerably lower
than group A's (P=0.003 and 0.001, respectively) compared to each other. In comparison to group A's alphafetoprotein (AFP) of 8.69±1.84, group B's AFP of 254.33±32.69 was statistically substantially higher (P =
0.001).Vitamin D levels in group B were substantially lower (19.33±4.68) than in group A (26.31±4.95) (P= 0.00).
With an area under the curve (AUC) of 0.802, vitamin D
multifunctional steroid hormone known as vitamin D. Vitamin D deficiency was found to be linked with advancement
of Chronic liver disease (CLD) as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), as well
as the hepatitis C virus (HCV). Objective: The aim of the current work was to investigate the association between
vitamin D deficiency and HCC in patients with liver cirrhosis. Patients and Methods: Ninety individuals with liver
cirrhosis (LC) participated in this trial. The included subjects were divided into two groups; Group A consisted of 45
cirrhotic patients without HCC, and Group B consisted of 45 cirrhotic patients with HCC. Results: Liver function
tests: INR, ALT, AST, total bilirubin were all statistically substantially higher in group B than in group A (P=0.001,
0.001, 0.001, and 0.011, respectively). However, group B's serum albumin and platelet count were considerably lower
than group A's (P=0.003 and 0.001, respectively) compared to each other. In comparison to group A's alphafetoprotein (AFP) of 8.69±1.84, group B's AFP of 254.33±32.69 was statistically substantially higher (P =
0.001).Vitamin D levels in group B were substantially lower (19.33±4.68) than in group A (26.31±4.95) (P= 0.00).
With an area under the curve (AUC) of 0.802, vitamin D
Staff Members - Benha University